Ligand validation:3O2W

SO4: SULFATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3O2W_SO4_L_224	73%	93%	0.097	0.922	0.2	0.28	-	-	0	0	100%	1
3O2W_SO4_H_244	66%	65%	0.176	0.982	0.24	1.08	-	-	0	0	100%	0.5
3O2W_SO4_L_225	63%	97%	0.106	0.901	0.12	0.18	-	-	0	0	100%	1
3O2W_SO4_H_245	44%	91%	0.209	0.937	0.2	0.36	-	-	0	0	100%	0.5
3O2W_SO4_H_246	40%	96%	0.151	0.861	0.17	0.19	-	-	0	0	100%	1
3O2W_SO4_L_223	36%	93%	0.172	0.864	0.12	0.35	-	-	0	0	100%	1
3O2W_SO4_H_247	24%	96%	0.166	0.794	0.18	0.19	-	-	0	0	100%	1
3O2W_SO4_L_220	21%	93%	0.218	0.827	0.21	0.26	-	-	0	0	100%	1
3O2W_SO4_L_222	12%	93%	0.247	0.776	0.18	0.29	-	-	0	0	100%	1
3O2W_SO4_L_221	11%	97%	0.165	0.679	0.11	0.21	-	-	0	0	100%	1
2O5X_SO4_H_411	99%	79%	0.055	0.993	0.27	0.58	-	-	0	0	100%	0.5
2O5Z_SO4_H_301	99%	93%	0.066	0.994	0.18	0.32	-	-	0	0	100%	0.5
2O5Y_SO4_H_246	89%	97%	0.108	0.988	0.18	0.13	-	-	0	0	100%	0.5
3O2V_SO4_H_246	88%	89%	0.102	0.978	0.16	0.46	-	-	1	0	100%	1
1BZ6_SO4_A_201	100%	87%	0.021	0.999	0.3	0.38	-	-	0	0	100%	1
1IJV_SO4_A_102	100%	92%	0.025	0.997	0.31	0.2	-	-	0	0	100%	1
1ON0_SO4_A_401	100%	97%	0.024	0.997	0.27	0.07	-	-	0	0	100%	1
1QU0_SO4_A_801	100%	93%	0.023	0.997	0.31	0.17	-	-	0	0	100%	1
1T2H_SO4_A_601	100%	95%	0.027	0.998	0.16	0.22	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.